But pressure on the supply of doses is now decreasing, said Aurelia Nguyen, chief programme officer of the Gavi vaccine alliance that raises funds to supply vaccines to developing countries.
“Due to the number of currently ongoing cholera outbreaks, our supply of vaccines was under pressure at the start of the year. But the pressure is now decreasing and we are once again in a position to immediately respond to new requests. “Cholera is part of the 10-year, $1 billion initiative aimed at supporting vaccine production in Africa.”“Climate change is a factor that is embedded in our new strategy. This is the first time that global warming has been a criteria for investment in future vaccinations — for example, against dengue fever.
“Gavi works closely with the WHO to keep an eye on new pathogens that may emerge, and we take climate shocks into account in our projections for future vaccine needs.